CAS RN: 916812-31-2
6-Bromo-N-methyl-4-quinolinamine
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
≥95% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20251229
100mg / 250mg / 1g / 5g
Confirm by inquiry
Shanghai Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 916812-31-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
916812-31-2 / 6-bromo-N-methylquinolin-4-amine
Standard CAS: 916812-31-2
Multi CAS: Yes
Basic Information
copy
CAS
916812-31-2 copy
Multi CAS
Yes copy
Molecular Formula
BC10H9Rn2 copy
Molecular Weight
237.100000 copy
Exact Mass
235.994910 copy
InChI
InChI=1S/C10H9BrN2/c1-12-9-4-5-13-10-3-2-7(11)6-8(9)10/h2-6H,1H3,(H,12,13) copy
InChIKey
FHWDWCUTMVHJCX-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
13 copy
Aromatic heavy atom count
10 copy
Fraction Csp3
0.1 copy
Rotatable bonds
1 copy
H-bond acceptors
2 copy
H-bond donors
1 copy
Molar refractivity
58.99 copy
TPSA
24.92 copy
LogP / Solubility
WLOGP
3.04 copy
MLOGP
2.68 copy
XLogP3
2.9 copy
Consensus LogP
2.87 copy
Log S (ESOL)
-3.73 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.7 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.84 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.01 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy